Deargen, a company specializing in AI new drug development, and Uptera, a new drug development company (TPD), announced on the 16th that they selected two target proteins, including anti-cancer drugs, and signed a joint research contract.
Read More
[Press Release] HANDOK Inc. and DEARGEN announce strategic collaboration to discover novel therapies for oncology
HANDOK Inc. and Deargen announced that the companies have entered into a strategic collaboration to discover and develop therapies for Oncology and other diseases.
Read More
대웅제약 자회사 아이엔테라퓨틱스, 디어젠과 난청치료제 개발
아이엔테라퓨틱스(대표 박종덕)는 디어젠(대표 강길수)의 AI플랫폼을 활용해 난청치료제 신약물질 발굴에 돌입했다고 17일 밝혔다. 아이엔테라퓨틱스는 대웅제약에서 분사된 신약개발 전문 자회사다.
Read More
[Press Release] DEARGEN and SKChemical announce strategic collaboration to drug discovery using AI platform
we announce our partnership with SK Chemical to co-develop AI-based new drugs. As part of this partnership, SKChemical and Deargen will conduct joint researches on “drug repositioning” and “de novo drug design.”
Read More
디어젠, pre-시리즈A 30억 유치.. ‘배영철 CBO 영입’
인공지능(AI) 기반 신약개발 전문기업인 디어젠(Deargen)이 pre-시리즈A로 30억원 규모의 투자유치를 마쳤다고 26일 밝혔다.
Read More
아밀로이드솔루션, AI 디어젠 인수.. ‘AD 신약개발 속도’
알츠하이머병 치료제 신약개발 기업인 아밀로이드솔루션(Amyloid Solution)이 인공지능(AI) 기반 신약개발 전문기업인 디어젠(Deargen)을 인수했다.
Read More
[공고] 신주발행공고
2020년 10월 7일 디어젠 주식회사의 이사회를 통해 다음과 같이 신주발행을 결의하였음을 공고합니다.
Read More
[Press Release] Optipharm and Deargen start developing vaccine for liver cancer treatment using AI
Optipharm and Deargen, Introduced AI to find antigens (epitopes) that cause immune responses to liver cancer cells.
Read More
[Event] DEARGEN, in ‘KOREA Pharm and Bio 2020’ Fair
DEARGEN participated in KOREA PHARM & BIO 2020 fair in KOREA and received a lot of interest. Especially for the case of COVID-19 treatment prediction using AI.
Read More
Five Companies Using AI to Fight Coronavirus
Deep learning models predict old and new drugs that might successfully treat COVID-19.
Read More